Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10858450 Bi-specific fusion proteins

Patent 10858450 was granted and assigned to Silver Creek Pharmaceuticals, Inc. on December, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
‌
Silver Creek Pharmaceuticals, Inc.
Date Filed
April 19, 2018
Date of Patent
December 8, 2020
Patent Applicant
‌
Silver Creek Pharmaceuticals, Inc.
Patent Application Number
15957252
Patent Citations
‌
US Patent 10407512 Bi-specific fusion proteins
Patent Citations Received
‌
US Patent 12122819 Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin A5 variant
0
‌
US Patent 11673970 Bi-specific fusion proteins
0
‌
US Patent 11879002 Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nucleic acids thereof
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10858450
Patent Primary Examiner
‌
Randall L Beane

Find more entities like US Patent 10858450 Bi-specific fusion proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo